We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RRC:NYSERange Resources Corporation Analysis

Data as of 2026-04-29 - not real-time

$42.94

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Range Resources is trading at $42.94, comfortably above its 20‑day SMA of 42.66 and 50‑day SMA of 42.40, but still below the 200‑day SMA of 37.74, indicating a short‑term bullish bias within a longer‑term uptrend. The stock sits on a solid support level around $40.27 and faces resistance near $47.01, with volume trending upward and a bullish trend direction flag despite a bearish MACD histogram. RSI hovers near 52, suggesting neutral momentum, while the beta of roughly 0.21 signals low market‑wide volatility relative to the broader index.
Fundamentally, RRC posted $3.21 B in revenue with 26% YoY growth, strong gross (52%) and operating (44%) margins, and a trailing EPS of $3.78 rising to a forward estimate of $4.63. The DCF fair value of $82.50 implies an upside of nearly 9%, the PE of 11.4 is well below the industry average of 22.2, and a modest 0.93% dividend yield is supported by a low payout ratio under 10% and robust free cash flow. Recent Q1 2026 results beat expectations, delivering $1.02 B revenue (+19% YoY) and EPS of $1.52, reinforcing confidence in continued cash generation and strategic execution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near strong support with increasing volume
  • Neutral momentum (RSI ~52) and bearish MACD histogram
  • Recent earnings beat and solid cash flow

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued valuation metrics (PE vs industry, DCF upside)
  • Consistent revenue growth and high operating margins
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value suggests significant upside
  • Strong balance sheet with modest debt and high ROE
  • Long‑term demand for natural gas and strategic positioning in the Appalachian basin

Key Metrics & Analysis

Financial Health

Revenue Growth26.10%
Profit Margin28.12%
P/E Ratio11.4
ROE21.13%
ROA10.91%
Debt/Equity21.27
P/B Ratio2.2
Op. Cash Flow$1.5B
Free Cash Flow$554.7M
Industry P/E22.2

Technical Analysis

TrendBullish
RSI52.0
Support$40.27
Resistance$47.01
MA 20$42.66
MA 50$42.40
MA 200$37.74
MACDBearish
VolumeIncreasing
Fear & Greed Index89.59

Valuation

Fair Value$82.50
Target Price$46.78
Upside/Downside8.95%
GradeUndervalued
TypeBlend
Dividend Yield0.93%

Risk Assessment

Beta0.21
Volatility31.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.